At close: December 16 at 4:00:01 PM EST
After hours: 7:53:46 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-30,757.0000
-47,590.0000
-57,554.0000
-26,306.0000
-16,551.0000
Financing Cash Flow
33,688.0000
40,450.0000
14,887.0000
40,269.0000
31,246.0000
End Cash Position
4,703.0000
4,928.0000
12,068.0000
54,735.0000
40,772.0000
Issuance of Capital Stock
26,000.0000
33,621.0000
17,620.0000
41,279.0000
33,267.0000
Repurchase of Capital Stock
--
--
-6.0000
--
--
Free Cash Flow
-30,757.0000
-47,590.0000
-57,554.0000
-26,306.0000
-16,551.0000
12/31/2020 - 12/19/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FBIO Fortress Biotech, Inc.
1.8500
-4.64%
TGTX TG Therapeutics, Inc.
34.40
+7.43%
LXRX Lexicon Pharmaceuticals, Inc.
0.7699
-4.99%
TNXP Tonix Pharmaceuticals Holding Corp.
0.5300
+120.37%
CRDF Cardiff Oncology, Inc.
4.0300
+2.81%
IBRX ImmunityBio, Inc.
3.0600
+6.62%
QURE uniQure N.V.
17.40
+12.99%
CMRX Chimerix, Inc.
2.9100
-1.36%
MGX Metagenomi, Inc.
3.1050
-4.17%
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.3000
-11.88%